You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

~ Buy the BENZYL BENZOATE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR BENZYL BENZOATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for benzyl benzoate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00119483 ↗ Older Men and Testosterone Completed University Hospital of North Norway N/A 2005-09-01 Male hypogonadism is a clinical situation characterized by a low serum testosterone level in combination with a diversity of symptoms and signs such as reduced libido and vitality, decreased muscle mass, increased fat mass and depression. Similar symptoms in combination with subnormal testosterone levels are seen in some elderly men. Low testosterone levels are associated with known cardiovascular risk factors, and men with diabetes and stroke have lower testosterone levels than healthy men. Even though several publications have suggested that testosterone treatment in hypogonadal men may have beneficial effects, it is still uncertain if testosterone substitution in the aging man is indicated. Despite this uncertainty the sale of testosterone has increased enormously the last few years. We hypothesize that older men with subnormal testosterone levels have a varying degree of dysfunction/symptoms both physically and mentally, and that these dysfunction/symptoms can be improved with testosterone treatment.
NCT02927210 ↗ Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) Recruiting Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 1 2016-12-01 This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
NCT02927210 ↗ Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) Recruiting Los Angeles Biomedical Research Institute Phase 1 2016-12-01 This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
NCT02927210 ↗ Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) Recruiting Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Phase 1 2016-12-01 This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
NCT02927210 ↗ Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) Recruiting University of Washington Phase 1 2016-12-01 This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
NCT02927210 ↗ Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) Recruiting Health Decisions Phase 1 2016-12-01 This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
NCT04205669 ↗ Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon Completed Bernhard Nocht Institute for Tropical Medicine Phase 4 2018-10-04 It is unclear whether individual treatment of scabies is similarly effective compared to household treatment. This study therefore compares these two treatment strategies with topical benzyl benzoate for treating scabies in Lambaréné and surroundings in Gabon. Subjects presenting with uncomplicated scabies are randomized into either the Individual Treatment group, where only the affected subjects receive treatment, or the Household Treatment group, where all family members are treated in parallel to the affected subjects regardless of signs and symptoms. The primary endpoint is clinical cure after 28 days; the secondary endpoint is the proportion of affected household members per household after 28 days.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for benzyl benzoate

Condition Name

Condition Name for benzyl benzoate
Intervention Trials
Cesarean Section 1
Healthy Men 1
Households 1
Hypogonadism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for benzyl benzoate
Intervention Trials
Chronic Pain 1
Acute Pain 1
Scabies 1
Hypogonadism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for benzyl benzoate

Trials by Country

Trials by Country for benzyl benzoate
Location Trials
United States 2
Norway 1
Taiwan 1
Gabon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for benzyl benzoate
Location Trials
Washington 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for benzyl benzoate

Clinical Trial Phase

Clinical Trial Phase for benzyl benzoate
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
Phase 1 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for benzyl benzoate
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for benzyl benzoate

Sponsor Name

Sponsor Name for benzyl benzoate
Sponsor Trials
Health Decisions 1
Bernhard Nocht Institute for Tropical Medicine 1
Medical University of Vienna 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for benzyl benzoate
Sponsor Trials
Other 10
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.